Genetic Disorders of Phosphate Homeostasis

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 1, Issue , 2010, Pages 1160-1175

  White, Kenneth E ^a   Bringhurst, F Richard ^b   Econs, Michael J ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Division of Endocrinology and Metabolism   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870488089     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00061-7     Document Type: Chapter

References (253)

1. M Walser (1961) Ion association. VI. Interactions between calcium, magnesium, inorganic phosphate, citrate and protein in normal human plasma. J Clin Invest 40 723-730.
2. A Somell and A Alveryd (1976) Diurnal variations in the urinary excretion of calcium and phosphate in hyperparathyroidism. Acta Chir Scand 142 357-359.
3. A Adam, J Boulanger, M Azzouzi, et al. (1984) Colorimetric vs enzymatic determination of serum phosphorus. Clin Chem 30 1724-1725.
4. RA Landowne (1979) Immunoglobulin interference with phosphorus and chloride determinations with the Coulter chemistry. Clin Chem 25 1189-1190.
5. JM Donhowe, EF Freier, ET Wong, et al. (1981) Factitious hypophosphatemia related to mannitol therapy. Clin Chem 27 1765-1769.
6. RM Pitkin, WA Reynolds, GA Williams, et al. (1979) Calcium metabolism in normal pregnancy: a longitudinal study. Am J Obstet Gynecol 133 781-790.
7. RG MacDonald and HN MacDonald (1977) Erythrocyte 2,3-diphosphoglycerate and associated haematological parameters during the menstrual cycle and pregnancy. Br J Obstet Gynaecol 84 427-433.
8. RE Reitz, TA Daane, JR Woods, et al. (1977) Calcium, magnesium, phosphorus, and parathyroid hormone interrelationships in pregnancy and newborn infants. Obstet Gynecol 50 701-705.
9. DP Cruikshank, RM Pitkin, WA Reynolds, et al. (1980) Altered maternal calcium homeostasis in diabetic pregnancy. J Clin Endocrinol Metab 50 264-267.
10. DT Baran, MP Whyte, MR Haussler, et al. (1980) Effect of the menstrual cycle on calcium-regulating hormones in the normal young woman. J Clin Endocrinol Metab 50 377-379.
11. L Hillman, S Sateesha, M Haussler, et al. (1981) Control of mineral homeostasis during lactation: interrelationships of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D, parathyroid hormone, calcitonin, prolactin, and estradiol. Am J Obstet Gynecol 139 471-476.
12. FR Greer, RC Tsang, JE Searcy, et al. (1982) Mineral homeostasis during lactation: relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin. Am J Clin Nutr 36 431-437.
13. RM Pitkin, DP Cruikshank, CW Schauberger, et al. (1980) Fetal calcitropic hormones and neonatal calcium homeostasis. Pediatrics 66 77-82.
14. JM Aitken, MJ Gallagher, DM Hart, et al. (1973) Plasma growth hormone and serum phosphorus concentrations in relation to the menopause and to oestrogen therapy. J Endocrinol 59 593-598.
15. BP Halloran, ET Lonergan and AA Portale (1996) Aging and renal responsiveness to parathyroid hormone in healthy men. J Clin Endocrinol Metab 81 2192-2197.
16. M Cirillo, C Ciacci and NG De Santo (2008) Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med 359 864-866.
17. AL Boskey and AS Posner (1977) The role of synthetic and bone extracted Ca-phospholipid-PO4 complexes in hydroxyapatite formation. Calcif Tissue Res 23 251-258.
18. JB Lian, L Cohen-Solal, D Kossiva, et al. (1982) Changes in phosphoproteins of chicken bone matrix in vitamin D-deficient rickets. FEBS Lett 149 123-125.
19. DH Marxhall, BE Nordin and R Speed (1976) Calcium, phosphorus and magnesium requirement. Proc Nutr Soc 35 163-173.
20. DR Wilz, RW Gray, JH Dominguez, et al. (1979) Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans. Am J Clin Nutr 32 2052-2060.
21. RH Wasserman and AN Taylor (1973) Intestinal absorption of phosphate in the chick: effect of vitamin D and other parameters. J Nutr 103 586-599.
22. S Kowarski and D Schachter (1969) Effects of vitamin D on phosphate transport and incorporation into mucosal constituents of rat intestinal mucosa. J Biol Chem 244 211-217.
23. S Hurwitz and A Bar (1965) Absorption of calcium and phosphorus along the gastrointestinal tract of the laying fowl as influenced by dietary calcium and egg shell formation. J Nutr 86 433-438.
24. DB Lee, MW Walling, DB Corry, et al. (1984) 1,25-Dihydroxyvitamin D3 stimulates calcium and phosphate absorption by different mechanisms: contrasting requirements for sodium. Adv Exp Med Biol 178 189-193.
25. G Danisi, H Murer and RW Straub (1984) Effects of pH and sodium on phosphate transport across brush border membrane vesicles of small intestine. Adv Exp Med Biol 178 173-180.
26. SM Borowitz and FK Ghishan (1989) Phosphate transport in human jejunal brush-border membrane vesicles. Gastroenterology 96 4-10.
27. H Hilfiker, O Hattenhauer, M Traebert, et al. (1998) Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A 95 14564-14569.
28. JA Feild, L Zhang, KA Brun, et al. (1999) Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine. Biochem Biophys Res Commun 258 578-582.
29. L Beck, AC Karaplis, N Amizuka, et al. (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95 5372-5377.
30. M Peterlik and RH Wasserman (1978) Effect of vitamin D on transepithelial phosphate transport in chick intestine. Am J Physiol 234 E379-E388.
31. H Murer and B Hildmann (1981) Transcellular transport of calcium and inorganic phosphate in the small intestinal epithelium. Am J Physiol 240 G409-G416.
32. TC Chen, L Castillo, M Korycka-Dahl, et al. (1974) Role of vitamin D metabolites in phosphate transport of rat intestine. J Nutr 104 1056-1060.
33. RA Corradino (1973) Embryonic chick intestine in organ culture. A unique system for the study of the intestinal calcium absorptive mechanism. J Cell Biol 58 64-78.
34. AS Brickman, DL Hartenbower, AW Norman, et al. (1977) Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus. Am J Clin Nutr 30 1064-1069.
35. MW Walling (1977) Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 233 E488-E494.
36. SJ Birge and R Miller (1977) The role of phosphate in the action of vitamin D on the intestine. J Clin Invest 60 980-988.
37. G Danisi and RW Straub (1980) Unidirectional influx of phosphate across the mucosal membrane of rabbit small intestine. Pflugers Arch 385 117-122.
38. HS Cross and M Peterlik (1984) Vitamin D activates (Na+-K+)ATPase: a possible regulation of phosphate and calcium uptake by cultured embryonic chick small intestine. Adv Exp Med Biol 178 163-171.
39. G Karsenty, B Lacour, A Ulmann, et al. (1985) Early effects of vitamin D metabolites on phosphate fluxes in isolated rat enterocytes. Am J Physiol 248 G40-G45.
40. R Fuchs and M Peterlik (1979) Vitamin D-induced transepithelial phosphate and calcium transport by chick jejunum. Effect of microfilamentous and microtubular inhibitors. FEBS Lett 100 357-359.
41. O Hattenhauer, M Traebert, H Murer, et al. (1999) Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol 277 G756-G762.
42. H Xu, L Bai, JF Collins, et al. (2002) Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). Am J Physiol Cell Physiol 282 C487-493.
43. H Segawa, I Kaneko, S Yamanaka, et al. (2004) Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287 F39-F47.
44. I Nemere, Y Yoshimoto and AW Norman (1984) Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology 115 1476-1483.
45. I Nemere (1996) Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25-dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3. Endocrinology 137 2254-2261.
46. GA Quamme (1985) Phosphate transport in intestinal brush-border membrane vesicles: effect of pH and dietary phosphate. Am J Physiol 249 G168-G176.
47. J Caverzasio, G Danisi, RW Straub, et al. (1987) Adaptation of phosphate transport to low phosphate diet in renal and intestinal brush border membrane vesicles: influence of sodium and pH. Pflugers Arch 409 333-336.
48. G Danisi, J Caverzasio, U Trechsel, et al. (1990) Phosphate transport adaptation in rat jejunum and plasma level of 1,25-dihydroxyvitamin D3. Scand J Gastroenterol 25 210-215.
49. HJ Armbrecht (1986) Age-related changes in calcium and phosphorus uptake by rat small intestine. Biochim Biophys Acta 882 281-286.
50. DB Lee, MW Walling and N Brautbar (1986) Intestinal phosphate absorption: influence of vitamin D and non-vitamin D factors. Am J Physiol 250 G369-G373.
51. CF Cramer and J McMillan (1980) Phosphorus adaptation in rats in absence of vitamin D or parathyroid glands. Am J Physiol 239 G261-G265.
52. FG Knox, H Osswald, GR Marchand, et al. (1977) Phosphate transport along the nephron. Am J Physiol 233 F261-F268.
53. VW Dennis, WW Stead and JL Myers (1979) Renal handling of phosphate and calcium. Annu Rev Physiol 41 257-271.
54. VW Dennis and PC Brazy (1982) Divalent anion transport in isolated renal tubules. Kidney Int 22 498-506.
55. C Amiel, H Kuntziger and G Richet (1970) Micropuncture study of handling of phosphate by proximal and distal nephron in normal and parathyroidectomized rat. Evidence for distal reabsorption. Pflugers Arch 317 93-109.
56. JA Haas, T Berndt and FG Knox (1978) Nephron heterogeneity of phosphate reabsorption. Am J Physiol 234 F287-F290.
57. C Le Grimellec, N Roinel and F Morel (1974) Simultaneous Mg, Ca, P, K and Cl analysis in rat tubular fluid. IV. During acute phosphate plasma loading. Pflugers Arch 346 189-204.
58. E Pastoriza-Munoz, RE Colindres, WE Lassiter, et al. (1978) Effect of parathyroid hormone on phosphate reabsorption in rat distal convolution. Am J Physiol 235 F321-F330.
59. RA Peraino and WN Suki (1980) Phosphate transport by isolated rabbit cortical collecting tubule. Am J Physiol 238 F358-F362.
60. GR Shareghi and ZS Agus (1982) Phosphate transport in the light segment of the rabbit cortical collecting tubule. Am J Physiol 242 F379-F384.
61. EG Schneider and LA McLane (1977) Evidence for a peritubular-to-luminal flux phosphate in the dog kidney. Am J Physiol 232 F159-F166.
62. KJ Ullrich (1978) Mechanisms of cellular phosphate transport in rat kidney proximal tubule. Adv Exp Med Biol 103 21-35.
63. KJ Ullrich, G Capasso, G Rumrich, et al. (1977) Coupling between proximal tubular transport processes. Studies with ouabain, SITS and HCO3-free solutions. Pflugers Arch 368 245-252.
64. KJ Ullrich and H Murer (1982) Sulphate and phosphate transport in the renal proximal tubule. Philos Trans R Soc Lond B Biol Sci 299 549-558.
65. N Hoffmann, M Thees and R Kinne (1976) Phosphate transport by isolated renal brush border vesicles. Pflugers Arch 362 147-156.
66. G Burckhardt, H Stern and H Murer (1981) The influence of pH on phosphate transport into rat renal brush border membrane vesicles. Pflugers Arch 390 191-197.
67. L Cheng and B Sacktor (1981) Sodium gradient-dependent phosphate transport in renal brush border membrane vesicles. J Biol Chem 256 1556-1564.
68. KJ Ullrich, G Rumrich and S Kloss (1978) Phosphate transport in the proximal convolution of the rat kidney. III. Effect of extracellular and intracellular pH. Pflugers Arch 377 33-42.
69. HM Hoag, J Martel, C Gauthier, et al. (1999) Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression. J Clin Invest 104 679-686.
70. N Zhao and HS Tenenhouse (2000) Npt2 gene disruption confers resistance to the inhibitory action of parathyroid hormone on renal sodium-phosphate cotransport. Endocrinology 141 2159-2165.
71. H Segawa, A Onitsuka, M Kuwahata, et al. (2008) Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol 20 104-113. –
72. RJ Walton and OL Bijvoet (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2 309-310.
73. MF Pfister, E Lederer, J Forgo, et al. (1997) Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem 272 20125-20130.
74. M Lotscher, P Wilson, S Nguyen, et al. (1996) New aspects of adaptation of rat renal Na-Pi cotransporter to alterations in dietary phosphate. Kidney Int 49 1012-1018.
75. F Takahashi, K Morita, K Katai, et al. (1998) Effects of dietary Pi on the renal Na+-dependent Pi transporter NaPi-2 in thyroparathyroidectomized rats. Biochem J 333(Pt 1), 175-181.
76. SA Kempson, M Lotscher, B Kaissling, et al. (1995) Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Physiol 268 F784-F791.
77. M Traebert, H Volkl, J Biber, et al. (2000) Luminal and contraluminal action of 1-34 and 3-34 PTH peptides on renal type IIa Na-P(i) cotransporter. Am J Physiol Renal Physiol 278 F792-F798.
78. D Bacic, N Schulz, J Biber, et al. (2003) Involvement of the MAPK-kinase pathway in the PTH-mediated regulation of the proximal tubule type IIa Na+/Pi cotransporter in mouse kidney. Pflugers Arch 446 52-60.
79. SF Wen (1974) Micropuncture studies of phosphate transport in the proximal tubule of the dog. The relationship to sodium reabsorption. J Clin Invest 53 143-153.
80. U Trohler, JP Bonjour and H Fleisch (1976) Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J Clin Invest 57 264-273.
81. S Goldfarb, GR Westby, M Goldberg, et al. (1977) Renal tubular effects of chronic phosphate depletion. J Clin Invest 59 770-779.
82. TH Steele and HF DeLuca (1976) Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat. J Clin Invest 57 867-874.
83. JD Crawford, MM Osborne Jr, NB Talbot, et al. (1950) The parathyroid glands and phosphorus homeostasis. J Clin Invest 29 1448-1461.
84. EL Chambers Jr, L Goldman, GS Gordan, et al. (1956) Tests for hyperparathyroidism: tubular reabsorption of phosphate, phosphate deprivation, and calcium infusion. J Clin Endocrinol Metab 16 1507-1521.
85. WW McCrory, CW Forman, NH Mc, et al. (1952) Renal excretion of inorganic phosphate in newborn infants. J Clin Invest 31 357-366.
86. J Caverzasio and JP Bonjour (1985) Mechanism of rapid phosphate (Pi) transport adaptation to a single low Pi meal in rat renal brush border membrane. Pflugers Arch 404 227-231.
87. DD Thompson and HH Hiatt (1957) Effects of phosphate loading and depletion on the renal excretion and reabsorption of inorganic phosphate. J Clin Invest 36 566-572.
88. KA Hruska, S Klahr and MR Hammerman (1982) Decreased luminal membrane transport of phosphate in chronic renal failure. Am J Physiol 242 F17-F22.
89. BS Levine, K Ho, A Hodsman, et al. (1984) Early renal brush border membrane adaptation to dietary phosphorus. Miner Electrolyte Metab 10 222-227.
90. MG Brunette, M Chan, U Maag, et al. (1984) Phosphate uptake by superficial and deep nephron brush border membranes. Effect of the dietary phosphate and parathyroid hormone. Pflugers Arch 400 356-362.
91. H Murer, H Stern, G Burckhardt, et al. (1980) Sodium-dependent transport of inorganic phosphate across the renal brush border membrane. Adv Exp Med Biol 128 11-23.
92. CJ Boyer, Y Xiao, A Dugre, et al. (1996) Phosphate deprivation induces overexpression of two proteins related to the rat renal phosphate cotransporter NaPi-2. Biochim Biophys Acta 1281 117-123.
93. M Lotscher, B Kaissling, J Biber, et al. (1997) Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content. J Clin Invest 99 1302-1312.
94. T Ritthaler, M Traebert, M Lotscher, et al. (1999) Effects of phosphate intake on distribution of type II Na/Pi cotransporter mRNA in rat kidney. Kidney Int 55 976-983.
95. M Levi, M Lotscher, V Sorribas, et al. (1994) Cellular mechanisms of acute and chronic adaptation of rat renal P(i) transporter to alterations in dietary P(i). Am J Physiol 267 F900-F908.
96. T Berndt, LF Thomas, TA Craig, et al. (2007) Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A 104 11085-11090.
97. T Larsson, R Marsell, E Schipani, et al. (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145 3087-3094.
98. T Shimada, H Hasegawa, Y Yamazaki, et al. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19 429-435.
99. SM Burnett, SC Gunawardene, FR Bringhurst, et al. (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21 1187-1196.
100. F Perwad, N Azam, MY Zhang, et al. (2005) Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146 5358-5364.
101. KB Jonsson, R Zahradnik, T Larsson, et al. (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348 1656-1663.
102. Y Yamazaki, R Okazaki, M Shibata, et al. (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87 4957-4960.
103. A Khosravi, CM Cutler, MH Kelly, et al. (2007) Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab 92 2374-2377.
104. Y Takeuchi, H Suzuki, S Ogura, et al. (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89 3979-3982.
105. MJ Econs and PT McEnery (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82 674-681.
106. JW Bianchine, AA Stambler and HE Harrison (1971) Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser 7 287-295.
107. MJ Econs, PT McEnery, F Lennon, et al. (1997) Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100 2653-2657.
108. ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26 345-348.
109. M Riminucci, MT Collins, NS Fedarko, et al. (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112 683-692.
110. S Liu, R Guo, LG Simpson, et al. (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278 37419-37426.
111. KE White, G Carn, B Lorenz-Depiereux, et al. (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60 2079-2086.
112. T Shimada, T Muto, I Urakawa, et al. (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143 3179-3182.
113. NG Seidah and M Chretien (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848 45-62.
114. SS Molloy, PA Bresnahan, SH Leppla, et al. (1992) Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267 16396-16402.
115. K Nakayama (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327(Pt 3), 625-635.
116. A Benet-Pages, B Lorenz-Depiereux, H Zischka, et al. (2004) FGF23 is processed by proprotein convertases but not by PHEX. Bone 35 455-462.
117. EA Imel, SL Hui and MJ Econs (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22 520-526.
118. EA Ryan and E Reiss (1984) Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77 501-512.
119. D Schapira, O Ben Izhak, A Nachtigal, et al. (1995) Tumor-induced osteomalacia. Semin Arthritis Rheum 25 35-46.
120. Q Cai, SF Hodgson, PC Kao, et al. (1994) Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 330 1645-1649.
121. MJ Econs, GP Samsa, M Monger, et al. (1994) X-Linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner 24 17-24.
122. SA Chalew, JC Lovchik, CM Brown, et al. (1996) Hypophosphatemia induced in mice by transplantation of a tumor-derived cell line from a patient with oncogenic rickets. J Pediatr Endocrinol Metab 9 593-597.
123. KE White, KB Jonsson, G Carn, et al. (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86 497-500.
124. T Shimada, S Mizutani, T Muto, et al. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98 6500-6505.
125. Tenenhouse HS, Econs MJ: Mendelian hypophosphatemias. In Scriver CR, editor: The metabolic and molecular basis of inherited disease, 1998, pp 5039–5068.
126. PEXConsortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet 11 130-136.
127. F Francis, TM Strom, S Hennig, et al. (1997) Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res 7 573-585.
128. L Beck, Y Soumounou, J Martel, et al. (1997) Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Phex gene in X-linked hypophosphatemic mice. J Clin Invest 99 1200-1209.
129. Y Wang, MK Spatz, K Kannan, et al. (1999) A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. Proc Natl Acad Sci U S A 96 4455-4460.
130. EM Eicher, JL Southard, CR Scriver, et al. (1976) Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A 73 4667-4671.
131. RA Meyer Jr, MH Meyer and RW Gray (1989) Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res 4 493-500.
132. TJ Weber, S Liu, OS Indridason, et al. (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18 1227-1234.
133. Y Aono, Y Yamazaki, J Yasutake, et al. (2009 May 6) Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/ssteomalacia. J Bone Miner Res [Epub ahead of print]
134. X Bai, D Miao, D Panda, et al. (2002) Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression. Mol Endocrinol 16 2913-2925.
135. S Liu, R Guo, Q Tu, et al. (2002) Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem 277 3686-3697.
136. RG Erben, D Mayer, K Weber, et al. (2005) Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype. J Bone Miner Res 20 1149-1160.
137. FH Glorieux, PJ Marie, JM Pettifor, et al. (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303 1023-1031.
138. FH Glorieux, CR Scriver, TM Reade, et al. (1972) Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 287 481-487.
139. T Costa, PJ Marie, CR Scriver, et al. (1981) X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab 52 463-472.
140. TO Carpenter, MA Mitnick, A Ellison, et al. (1994) Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J Clin Endocrinol Metab 78 1378-1383.
141. EA Imel, LA DiMeglio, SL Hui, et al. (2007) Treatment of XLH with calcitriol and phosphate increases FGF23 concentration. J Bone Miner Res 22(Suppl 1), W123.S123.
142. IR Reid, DC Hardy, WA Murphy, et al. (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine (Baltimore) 68 336-352.
143. PR Goodyer, JB Kronick, S Jequier, et al. (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111 700-704.
144. GB Stickler and BZ Morgenstern (1989) Hypophosphataemic rickets: final height and clinical symptoms in adults. Lancet 2 902-905.
145. S Balsan and M Tieder (1990) Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J Pediatr 116 365-371.
146. A Bettinelli, ML Bianchi, E Mazzucchi, et al. (1991) Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. J Pediatr 118 372-376.
147. CF Verge, A Lam, JM Simpson, et al. (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325 1843-1848.
148. GS Reusz, K Latta, PF Hoyer, et al. (1990) Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets. Lancet 335 1240-1243.
149. MC Eddy, WH McAlister and MP Whyte (1997) X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia. Bone 21 515-520.
150. U Alon, DL Donaldson, S Hellerstein, et al. (1992) Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse. J Pediatr 120 899-905.
151. H Rasmussen, C Anast (1983) Familial hypophosphatemic rickets and vitamin D-dependent rickets. JB Stanbury, JB Wyngaarden, DS Fredrickson, et al., (Eds) The metabolic basis of inherited disease ed 5 New York: McGraw-Hill 1743.
152. H Rasmussen and HS Tenenhouse (1989) Hypophosphatemias. CR Scriver, AL Beaudet, WS Sly, D Valle,(Eds) The metabolic basis of inherited disease ed 6 New York: McGraw Hill 2581.
153. TD Blydt-Hansen, HS Tenenhouse and P Goodyer (1999) PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 13 607-611.
154. RG Firth, CS Grant and BL Riggs (1985) Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases. Am J Med 78 669-673.
155. DM Wilson, PD Lee, AH Morris, et al. (1991) Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145 1165-1170.
156. TO Carpenter, M Keller, D Schwartz, et al. (1996) 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets: a clinical research center study. J Clin Endocrinol Metab 81 2381-2388.
157. JD Hanna, K Niimi and JC Chan (1991) X-linked hypophosphatemia. Genetic and clinical correlates. Am J Dis Child 145 865-870.
158. MK Drezner, KW Lyles, MR Haussler, et al. (1980) Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest 66 1020-1032.
159. H Rasmussen, M Pechet, C Anast, et al. (1981) Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3. J Pediatr 99 16-25.
160. RM Harrell, KW Lyles, JM Harrelson, et al. (1985) Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest 75 1858-1868.
161. RW Chesney, RB Mazess, P Rose, et al. (1983) Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71 559-567.
162. JQ Feng, LM Ward, S Liu, et al. (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38 1310-1315.
163. B Lorenz-Depiereux, M Bastepe, A Benet-Pages, et al. (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38 1248-1250.
164. WF Schwindinger, CA Francomano and MA Levine (1992) Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 89 5152-5156.
165. LS Weinstein, A Shenker, PV Gejman, et al. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325 1688-1695.
166. F Albright, A Butler and E Bloomberg (1937) Rickets resistant to vitamin D therapy. Am J Dis Child 54 529-547.
167. MT Collins, C Chebli, J Jones, et al. (2001) Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16 806-813.
168. T Yamamoto, Y Imanishi, E Kinoshita, et al. (2005) The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome. J Bone Miner Metab 23 231-237.
169. AL Folpe, JC Fanburg-Smith, SD Billings, et al. (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28 1-30.
170. P Beighton, BJ Cremin and K Kozlowski (1980) Osteoglophonic dwarfism. Pediatr Radiol 10 46-50.
171. KE White, JM Cabral, SI Davis, et al. (2005) Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet 76 361-367.
172. FH Lovejoy Jr and WE Boyle Jr (1973) Linear nevus sebaceous syndrome: report of two cases and a review of the literature. Pediatrics 52 382-387.
173. AH Mehregan and I Hardin (1973) Generalized follicular hamartoma. Complicated by multiple proliferating trichilemmal cysts and palmar pits. Arch Dermatol 107 435-438.
174. MC Brodsky, JM Kincannon, P Nelson-Adesokan, et al. (1997) Oculocerebral dysgenesis in the linear nevus sebaceous syndrome. Ophthalmology 104 497-503.
175. DE Carey, MK Drezner, JA Hamdan, et al. (1986) Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. J Pediatr 109 994-1000.
176. WH Hoffman, HW Jueppner, BR Deyoung, et al. (2005) Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am J Med Genet A 134 233-236.
177. A Inclan, P Leon and M Camjeo (1943) Tumoral calcinosis. JAMA 121 490-495.
178. PD Mitnick, S Goldfarb, E Slatopolsky, et al. (1980) Calcium and phosphate metabolism in tumoral calcinosis. Ann Intern Med 92 482-487.
179. MJ Prince, PC Schaeffer, RS Goldsmith, et al. (1982) Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. Ann Intern Med 96 586-591.
180. Y Frishberg, O Topaz, R Bergman, et al. (2005) Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med 83 33-38.
181. S Ichikawa, V Guigonis, EA Imel, et al. (2007) Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 92 1943-1947.
182. O Topaz, DL Shurman, R Bergman, et al. (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36 579-581.
183. S Ichikawa, KW Lyles and MJ Econs (2005) A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive. J Clin Endocrinol Metab 90 2420-2423.
184. HJ Garringer, C Fisher, TE Larsson, et al. (2006) The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab 91 4037-4042.
185. S Ichikawa, EA Imel, AH Sorenson, et al. (2006) Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene. J Clin Endocrinol Metab 91 4472-4475.
186. Y Frishberg, N Ito, C Rinat, et al. (2007) Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 22 235-242.
187. A Benet-Pages, P Orlik, TM Strom, et al. (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14 385-390.
188. T Larsson, X Yu, SI Davis, et al. (2005) A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90 2424-2427.
189. K Araya, S Fukumoto, R Backenroth, et al. (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90 5523-5527.
190. HJ Garringer, M Malekpour, F Esteghamat, et al. (2008) Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 295 E929-937.
191. I Chefetz, R Heller, A Galli-Tsinopoulou, et al. (2005) A novel homozygous missense mutation in FGF23 causes familial tumoral calcinosis associated with disseminated visceral calcification. Hum Genet 118 261-266.
192. T Larsson, SI Davis, HJ Garringer, et al. (2005) Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 146 3883-3891.
193. I Urakawa, Y Yamazaki, T Shimada, et al. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 770-774.
194. BC Lin, M Wang, C Blackmore, et al. (2007) Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 282 27277-27284.
195. H Kurosu, M Choi, Y Ogawa, et al. (2007) Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 282 26687-26695.
196. H Tsujikawa, Y Kurotaki, T Fujimori, et al. (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17 2393-2403.
197. T Shimada, M Kakitani, Y Yamazaki, et al. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113 561-568.
198. H Segawa, S Yamanaka, Y Ohno, et al. (2007) Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292 F769-F779.
199. D Sitara, MS Razzaque, M Hesse, et al. (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23 421-432.
200. SA Li, M Watanabe, H Yamada, et al. (2004) Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 29 91-99.
201. Y Matsumura, H Aizawa, T Shiraki-Iida, et al. (1998) Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242 626-630.
202. H Kurosu, Y Ogawa, M Miyoshi, et al. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281 6120-6123.
203. EG Farrow, SI Davis, LJ Summers, et al. (2009) Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20 955-960.
204. S Ichikawa, EA Imel, ML Kreiter, et al. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117 2684-2691.
205. CA Brownstein, F Adler, C Nelson-Williams, et al. (2008) A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci U S A 105 3455-3460.
206. M Tieder, D Modai, R Samuel, et al. (1985) Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312 611-617.
207. M Tieder, D Modai, U Shaked, et al. (1987) “Idiopathic” hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 316 125-129.
208. C Bergwitz, NM Roslin, M Tieder, et al. (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78 179-192.
209. B Lorenz-Depiereux, A Benet-Pages, G Eckstein, et al. (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78 193-201.
210. S Ichikawa, AH Sorenson, EA Imel, et al. (2006) Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab 91 4022-4027.
211. M Levi (2008) Novel NaPi-2c mutations that cause mistargeting of NaPi-2c protein and uncoupling of Na-Pi cotransport cause HHRH. Am J Physiol Renal Physiol 295 F369-F370.
212. G Jaureguiberry, TO Carpenter, S Forman, et al. (2008) A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am J Physiol Renal Physiol 295 F371-F379.
213. SE Lloyd, W Gunther, SH Pearce, et al. (1997) Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 6 1233-1239.
214. K Konishi, M Nakamura, H Yamakawa, et al. (1991) Case report: hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 301 322-328.
215. P Raskin and CYC Pak (1981) The effect of chronic insulin therapy on phosphate metabolism in diabetes mellitus. Diabetologia 21 50-53.
216. MJ Dillon, V Shah and MD Mitchell (1979) Bartter's syndrome: 10 cases in childhood. Q J Med 48 429-446.
217. W Jubiz, JM Canterbury, E Reiss, et al. (1972) Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin and growth hormone levels. J Clin Invest 51 2040-2046.
218. L Larsson, K Rebel and B Sorbo (1983) Severe hypophosphatemia: a hospital survey. Acta Med Scand 214 221-223.
219. S Weinstein, AG Scottolini and NV Bhagavan (1985) Low neutrophl alkaline phosphatase in renal tubular acidosis with hypophosphatemia after toluene sniffing. Clin Chem 31 330-331.
220. J Aschan, O Ringden, P Ljungman, et al. (1992) Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scand J Infect Dis 24 143-150.
221. J Perek, M Mettelman, U Gafter, et al. (1984) Hypophosphatemia accompanying blastic crisis in a patient with malignant lymphoma. J Cancer Res Clin Oncol 108 351-353.
222. R Clark and E Lee (1995) Severe hypophosphatemia during stem cell harvesting in chronic myeloid leukaemia. Br J Haematol 90 450-452.
223. JP Knochel (1982) Neuromuscular manifestations of electrolyte disorders. Am J Med 72 521-535.
224. SE Silvis, AG DiBartolomeo and HM Aaker (1980) Hypophosphatemia and neurological changes secondary to oral caloric intake. Am J Gastroenterol 73 215-222.
225. SE Silvis and PU Paragas Jr (1972) Paresthesias, weakness, seizures and hypophosphatemia in patients receiving hyperalimentation. Gastroenterology 62 513.
226. AJ Furlan, M Hanson, A Cooperman, et al. (1975) Acute areflexic paralysis. Association with hyperalimentation and hypophosphatemia. Arch Neurol 32 706-707.
227. LR O'Connor, KL Klein and JE Bethune (1977) Hyperphosphatemia in lactic acidosis. N Engl J Med 297 707-709.
228. AW Michell, DJ Burn and PJ Reading (2003) Central pontine myelinolysis temporally related to hypophosphataemia. J Neurol Neurosurg Psychiatry 74 820.
229. TJ Fuller, NW Carter, C Barcenas, et al. (1976) Reversible changes of the muscle cell in experimental phosphorus deficiency. J Clin Invest 57 1019-1024.
230. JH Newman, TA Neff and P Ziporin (1977) Acute respiratory failure associated with hypophosphatemia. N Engl J Med 296 1101.
231. M Aubier, D Murciano, Y Lecocguic, et al. (1985) Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 313 420-424.
232. T Gravelyn, N Brophy, C Siegert, et al. (1988) Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population. Am J Med 84 870-876.
233. A Rasmussen, S Buus and I Hessov (1985) Postoperative myocardial performance during glucose-induced hypophosphatemia. Acta Chir Scand 151 13-15.
234. P-E Bollaert, B Levy, L Nace, et al. (1995) Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 107 1698-1701.
235. JW Coburn and SG Massry (1970) Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest 49 1073-1087.
236. ZS Agus, LB Gardner, LH Beck, et al. (1973) Effects of parathyroid hornone on renal tubular reabsorption of calcium, sodium, and phosphate. Am J Physiol 224 1143-1148.
237. M Emmett, S Goldfarb, ZS Agus, et al. (1977) The pathophysiology of acid-base changes in chronically phosphate-depleted rats. J Clin Invest 59 291.
238. MA Lichtman, DR Miller, J Cohen, et al. (1971) Reduced red cell glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration and increased hemoglobin oxygen affinity caused by hypophosphatemia. Ann Intern Med 74 562-568.
239. JC Klock, HE Williams and WC Mentzer (1974) Hemolytic anemia and somatic cell dysfunction in severe hypophosphatemia. Arch Intern 134 360-364.
240. JS Jacob and P Amsden (1971) Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med 285 1446.
241. DH Marshall, BEC Nordin and R Speed (1976) Calcium, phosphorus and magnesium requirements. Proc Nutr Soc 35 163-173.
242. GB Garner, et al. (1967) Dietary phosphorus and salmonellosis in guinea pigs. Fed Proc 26 799.
243. K Rajan (1973) Hepatic hypoxia secondary to hypophosphatemia. Clin Res 23 521.
244. PR Craddock, Y Yawata, L VanSanten, et al. (1974) Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med 290 1403-1407.
245. RD Lentz, DM Brown and CM Kjellstrand (1978) Treatment of severe hypophosphatemia. Ann Intern Med 89 941-944.
246. G Rosen, J Boullata, E O'Rangers, et al. (1995) Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med 23 1204-1210.
247. C Clark, G Sacks, R Dickerson, et al. (1995) Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial. Crit Care Med 23 1504-1511.
248. RJ Winter, CJ Harris, LS Phillips, et al. (1979) Diabetic ketoacidosis. Induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am J Med 67 897-900.
249. NB Zipp, GE Bacon, ML Spencer, et al. (1979) Hypocalcemia, hypomagnesemia and transient hypoparathyroidism during therapy with potassium phosphate in diabetic ketoacidosis. Diabetes Care 2 265.
250. BE Taylor, WY Huey, TG Buchman, et al. (2004) Treatment of hypophosphatemia using a protocol based on patient weight and serum phosphorus level in a surgical intensive care unit. J Am Coll Surg 198 198-204.
251. K Kruse, D Woelfel and TM Strom (2001) Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res 55 305-308.
252. AL Negri, T Negrotti, G Alonso, et al. (2004) [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family]. Medicina (B Aires) 64 103-106.
253. L Masi, A Gozzini, A Franchi, et al. (2009) A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Joint Surg Am 91 1190-1198.